ReviewPregnancy (Hoboken, N.J.)2025
Cost-effectiveness of interventions for screening, treatment, and management of diabetes mellitus during pregnancy: A systematic review.
Review in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes is the most common noncommunicable disease in pregnancy, and incidence is rising globally. This systematic review aimed to synthesize economic evidence on diverse interventions available for managing diabetes during pregnancy. Methods: MEDLINE, Embase, CINAHL, PsycINFO, Global Index Medicus, and EconLit were searched from inception to November 30, 2024. Key terms related to pregnancy, diabetes mellitus, and economic evaluations were used. Studies were eligible for inclusion if they were full economic evaluations of any intervention for the screening, diagnosis, monitoring, or treatment of diabetes mellitus and/or its complications during pregnancy. Screening of studies, data extraction, and quality assessment (using the Consensus on Health Economic Criteria extended checklist) were conducted independently by two reviewers. Results: Thirty-five studies were included and categorized as: screening and diagnosis ( Conclusions: Several interventions for screening, diagnosing, and managing diabetes in pregnancy are likely to be cost-effective and can reduce health system costs. Further cost-effectiveness research is required to support the implementation of effective interventions, particularly in limited-resource settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.